Value of recombinant human thyrotropin in high-dose radioiodine therapy: a case report
V Müller, KH Bohuslavizki, S Klutmann… - Journal of nuclear …, 2002 - Soc Nuclear Med
We report on a high-dose radioiodine therapy after injection of recombinant human
thyrotropin (rhTSH) in a 61-y-old woman with compression of the spinal cord caused by …
thyrotropin (rhTSH) in a 61-y-old woman with compression of the spinal cord caused by …
Compassionate use of recombinant human thyrotropin to facilitate radioiodine therapy: case report and review of literature
RJ Robbins, E Voelker, W Wang, HA Macapinlac… - Endocrine Practice, 2000 - Elsevier
Objective To describe the use of recombinant human thyrotropin (thyroid-stimulating
hormone)(rhTSH) to assist in radioiodine therapy in a patient with thyroid carcinoma who …
hormone)(rhTSH) to assist in radioiodine therapy in a patient with thyroid carcinoma who …
Reproducibility of whole-body 131I scan and serum thyrotropin and stimulated thyroglobulin values in patients studied twice after injection of recombinant human …
RD Niederkohr, IR McDougall - European Journal of Nuclear Medicine …, 2007 - Springer
Abstract Purpose Recombinant human TSH (rhTSH) is used to increase radioiodine uptake
during imaging of thyroid cancer, obviating the need to render the patient hypothyroid. We …
during imaging of thyroid cancer, obviating the need to render the patient hypothyroid. We …
Recombinant human thyrotropin (rhTSH) in the management of differentiated thyroid cancer
JM Durski, RJ Weigel, IR McDougall - Nuclear medicine …, 2000 - journals.lww.com
Recombinant human thyrotropin (rhTSH) has been evaluated in 38 patients with
differentiated thyroid cancer. The patients had all been treated previously by operation and …
differentiated thyroid cancer. The patients had all been treated previously by operation and …
Clinical comparison of whole-body radioiodine scan and serum thyroglobulin after stimulation with recombinant human thyrotropin
BR Haugen, EC Ridgway, BA McLaughlin… - Thyroid, 2002 - liebertpub.com
Sensitive monitoring for thyroid cancer recurrence or persistence includes whole-body
radioiodine scanning (WBS) and measurement of serum thyroglobulin (Tg) after …
radioiodine scanning (WBS) and measurement of serum thyroglobulin (Tg) after …
Serum thyroglobulin concentrations and 131I whole-body scan results in patients with differentiated thyroid carcinoma after administration of recombinant human …
A David, A Blotta, M Bondanelli, R Rossi… - Journal of Nuclear …, 2001 - Soc Nuclear Med
The use of recombinant human thyroid-stimulating hormone (rhTSH) has recently become
available as an alternative diagnostic tool to assess the persistence and recurrence of …
available as an alternative diagnostic tool to assess the persistence and recurrence of …
Coming of age: Recombinant human thyroid-stimulating hormone as a preparation for 131I therapy in thyroid cancer
RJ Robbins, KS Pentlow - Journal of Nuclear Medicine, 2003 - Soc Nuclear Med
Recombinant human thyroid-stimulating hormone (rhTSH) was approved for diagnostic
testing by the US Food and Drug Administration in November 1998. It has subsequently …
testing by the US Food and Drug Administration in November 1998. It has subsequently …
Use of recombinant human thyrotropin in a complicated case of metastatic papillary thyroid carcinoma
SN Aslam, RG Daly - Endocrine Practice, 2001 - Elsevier
Objective To describe a complicated case of metastatic papillary thyroid carcinoma and the
use of recombinant human thyrotropin (thyroid-stimulating hormone)(rhTSH) in conjunction …
use of recombinant human thyrotropin (thyroid-stimulating hormone)(rhTSH) in conjunction …
[HTML][HTML] Failure of iodine uptake in microscopic pulmonary metastases after recombinant human thyroid-stimulating hormone stimulation
C Lawhn-Heath, R Flavell, E Chuang… - World Journal of …, 2020 - thieme-connect.com
Elevated thyroid stimulating hormone (TSH) is required when preparing for radioactive
iodine therapy in patients with differentiated thyroid cancer. Recombinant human TSH …
iodine therapy in patients with differentiated thyroid cancer. Recombinant human TSH …
Analysis of clinical factors for the determination of optimal serum level of thyrotropin after recombinant human thyroid-stimulating hormone administration
Purpose To determine the optimal levels of thyroid-stimulating hormone (TSH) levels after
administration of recombinant human TSH (rhTSH) to patients with differentiated thyroid …
administration of recombinant human TSH (rhTSH) to patients with differentiated thyroid …